Aviva Life Insurance Review: Cover, Cost and the Documents Behind It

Affiliate disclosure: we may earn a commission if you take out a product through links on this page. It costs you nothing extra and does not influence how providers are listed.

Aviva's Life Insurance Plan is advertised from £5 a month, takes applicants aged 18 to 77, runs for terms of 1 to 50 years, and includes terminal illness cover at no extra charge. Those figures were checked on 3 October 2026 against Aviva's own policy summary, document DA03008 05/2023, and its consumer product pages.

The company behind them is the largest life insurer in the United Kingdom, with roughly a 25% share of the market, 21.8 million UK customers and more than 325 years of trading. In 2025 it paid £1.99bn across 61,632 individual and group protection claims, and it accepted 98.7% of individual life and terminal illness claims — 40,277 of them, worth £860.67m. The plan carries a Defaqto 5 Star rating, although Aviva's page does not date it.

One thing worth knowing before you start a quote: the sale is a direct, non-advised one. You buy from Aviva UK Digital Limited, and the policy itself is written by Aviva Life & Pensions UK Limited, the group's life company. There is no fee for the sale and no broker in the chain, so the firm answering the phone and the firm paying the claim are parts of the same business.

£5 a month, £229 a year, and the distance between them

The £5 figure on Aviva's page is a floor, not a forecast, and the gap between it and what people actually pay is now a published number. The Financial Conduct Authority collected policy-level data from 11 insurers covering between 75% and 95% of all pure protection policies sold, and found that the median term assurance policy sold in 2024 carried an annual premium of £229 — about £19.08 a month, almost four times the advertised entry price.

The spread around that median is wide. Half of term assurance policies sold fell between £132 and £378 a year, and 80% between £82 and £630. At the bottom of that range you are close to Aviva's £5; at the top you are paying £52.50 a month for the same category of product. Price on a life policy is driven by age, health, smoking status, the sum assured and the term, and none of those is knowable until the questions have been answered.

Aviva does not publish a minimum or a maximum cover amount for this plan on either its product page or its policy summary. That is not unusual for the market, but it does mean the only way to find out what £5 buys at your age is to take the quote. The arithmetic that follows in the rest of this page uses Aviva's own published rules rather than a quoted price, because the rules apply to everybody and the price does not.

What the plan pays, and the three dates that decide whether it pays at all

This is a protection contract and nothing else. It pays a lump sum if the life covered dies during the term, or on an earlier diagnosis of terminal illness. Aviva's terms define that as "a definite diagnosis by the attending consultant of an illness that satisfies both of the following: the illness either has no known cure or has progressed to the point where it cannot be cured, and in the opinion of the attending consultant, the illness is expected to lead to death within 12 months". The judgement belongs to the treating consultant, not to Aviva's own doctor, which is the more generous of the two common constructions.

Three dates matter. The first is 12 months from the start, because Aviva will not pay if the life covered dies by suicide or intentional self-inflicted injury inside that window. The second is 60 days, the grace period on a missed premium; miss the whole 60 and the policy is cancelled, and because the plan has no cash-in value at any time there is nothing to show for the premiums already paid. The third is the 91st birthday of the oldest life covered, which every policy term has to end before.

The cooling-off period runs for 30 days from the later of the policy start and the arrival of the documents, with premiums refunded in full. After that, cancelling simply ends the cover on the day before the next premium is due and returns nothing.

Two Aviva companies, one phone call

The services document for this plan, reference GN14004 04/2024, is unusually plain about the structure. Aviva UK Digital Limited — company 09766150, firm reference 728985, registered at 8 Surrey Street in Norwich — sells the product. Aviva Life & Pensions UK Limited — company 3253947, firm reference 185896, registered at Wellington Row in York — provides and underwrites it.

That document also states, in terms, that "you will not receive advice or a personal recommendation from us for life insurance, critical illness cover and income protection". The sale is information-only. You choose the sum assured, the term and the shape of the cover, and nobody at Aviva is on the hook for whether those choices suit you. For a reader who knows what they want that is a cost saved; for one who does not, it is the single most important sentence in the pack.

The same document says there is no fee, and then explains how the sale is paid for: "Aviva Life & Pensions UK Limited pays commission to Aviva UK Digital Limited for selling this product." Commission moving between two companies in the same group is not a cost the customer sees as a line item, and it is a long way from the indemnity commission that drives the intermediated market. It is still worth knowing that a direct sale is not a commission-free one.

The policy is long-term insurance business, so the Financial Services Compensation Scheme covers up to 100% of a successful claim with no upper limit, and complaints go to Aviva Customer Relations at PO Box 3182, Norwich NR1 3XE before the Financial Ombudsman Service.

What Aviva actually paid out in 2025

Aviva published its 2025 protection claims figures on 25 March 2026, and they are the best available answer to the question everybody asks about life insurance. Across individual and group protection the group paid £1.99bn on 61,632 claims. The individual book — the one this plan sits in — accounted for 51,222 claims worth £1.315bn.

Within that, life and terminal illness claims numbered 40,277 and came to £860.67m, an average of £21,368 a claim, and Aviva accepted 98.7% of them. Critical illness, children's cover and total permanent disability claims ran at a 90.7% acceptance rate across 5,586 claims worth £388.56m, and income protection at 90% across 4,154 claims worth £63.56m. The lower acceptance rates on the latter two are a feature of how those products are defined rather than a sign of a harder claims line: a death is a fact, a listed critical illness is a definition that has to be met.

Two caveats on reading those numbers. They are group-wide across every distribution channel, not specific to policies bought direct through this plan, and the 98.7% figure covers the whole individual life book, including policies written through advisers and through workplace schemes.

The inflation option costs more than it adds

Aviva offers an increasing cover option so that the sum assured keeps pace with prices. The terms set out both halves of the deal. The cover amount rises each year in line with the Consumer Prices Index, and "the maximum annual increase applied will be 10%". The premium rises too: Aviva will "multiply your current premium by 1.5 and the percentage increase in CPI", capped so that "your premium won't increase by more than 15% each year". If CPI does not rise, neither the cover nor the premium moves.

Multiplying the premium increase by 1.5 while the cover increase is left at 1.0 means the price of each £1,000 of cover rises every year the option is in force. At 3% CPI, after 10 years the cover has grown 34.4% and the premium 55.3%, so each £1,000 of cover costs 15.6% more than it did at the start. After 25 years the cover has grown 109.4% and the premium 200.5%, and the same £1,000 of cover costs 43.5% more.

Put in money: start at £20 a month for £100,000 of cover and run 25 years at 3% CPI. The cover ends at £209,378 and the premium at £60.11 a month. Total premiums over the 25 years come to roughly £10,696, against £6,000 if the cover had been left level. The option is not a trick — Aviva publishes both multipliers in the terms, and index-linked cover genuinely is worth more than fixed cover — but it is priced at a premium to the indexation it delivers, and the gap compounds. Anyone taking it should ask themselves whether they would rather buy more level cover now for the same money.

Decreasing cover assumes 8%, and your mortgage probably does not

Decreasing cover is sold to track a repayment mortgage down to zero, and Aviva is more candid than most about the mechanism: the terms say the cover amount "decreases every month, broadly in line with a repayment loan, for example a mortgage, using a fixed interest rate of 8%". Publishing that figure is to Aviva's credit. The problem is the figure itself.

Eight per cent is well above anything on offer. The Bank of England put the effective interest rate on new fixed-rate mortgages at 4.20% in May 2026, and Moneyfacts had the average two-year fix at 5.68% in June 2026. Because a higher assumed rate means more of each early payment goes on interest, Aviva's cover falls more slowly than a real mortgage balance does — so the mismatch leaves you over-covered rather than short.

On a £200,000 repayment mortgage over 25 years at 4.20%, the debt stands at £143,766 after ten years while the Aviva cover is still £161,527: £17,761 more cover than mortgage, or 12.4%. By year 20 the gap is £17,887 on a debt of £58,242 — 30.7%. At 5.68% the gaps narrow to £10,345 and £10,984. Nobody is left exposed by this, and that is the right way round for a safety net to fail. But you are paying for cover you cannot use, and on a long policy the overlap runs into tens of thousands of pounds. A reader with a cheap fix and a long term should price level cover at the real outstanding balance against decreasing cover at Aviva's 8% before assuming the decreasing option is the economical one.

What the regulator concluded about this market in September

The Financial Conduct Authority closed its pure protection market study on 21 September 2026 with final report MS24/1.5, and the headline conclusion is favourable to insurers. The regulator found that "competition generally delivers good outcomes for people who hold these products, with a wide range of products available and high claims acceptance rates", and chose to act through existing rules rather than new regulation, with industry work starting by the end of 2026 and a TechSprint planned for the third quarter of 2027.

The problem it identified is not the product but the absence of it. Some 58% of UK adults hold no pure protection product at all, and 59% of those have never considered whether they need one. Unnecessary switching affects roughly 19,000 customers a year, about 0.1% of policyholders.

The commission findings are where a direct buyer has something to compare against. On term assurance the FCA found a median commission rate in 2024 of 220% of the first year's premium, equivalent to about 20% of the lifetime projected premiums on the policy, with the median clawback period having moved from two years to four. Around 80% of term assurance policies are sold through intermediaries, 88.9% of those on indemnity commission paid up front; 68% of intermediated sales ran through restricted panels, 27% through whole-of-market panels and 4% through single-tie arrangements. Buying direct from an insurer does not escape commission — Aviva's own services document says so — but it does take the four-year clawback and the panel question off the table.

Aviva's own complaints figures, and the gaps in the paperwork

Aviva UK Digital Limited publishes its complaints return, and for the half-year from 1 January to 30 June 2026 the selling entity opened 164 insurance and pure protection complaints and closed 151. The rate was 0.04 complaints per 1,000 sales, which is low. Of those closed, 37.1% were resolved within three days and 60.9% between three days and eight weeks, and 34.4% were upheld. The largest single cause was "advising, selling and arranging" — which, on a sale Aviva's own paperwork describes as carrying no advice, is worth noting.

The Financial Ombudsman Service's annual figures for 2025/26, published on 21 May 2026, put term assurance at 884 new cases with 17% upheld, against 214,600 complaints across all products and a 30% average. Critical illness cover ran at 647 cases and 12% upheld. Life cover generates very few complaints relative to its size, and the ones it does generate are upheld at around half the rate of the market as a whole.

Three things in the documents are harder to defend. The policy summary and terms and conditions both carry 05/2023 version dates and the services document 04/2024, so the consumer pack has not been refreshed in over two years while the product pages have. Neither document states a minimum or a maximum cover amount, so the sum you can actually buy is invisible until you start a quote. And the Defaqto 5 Star rating on the product page carries no year, no product name and no link to the assessment, which makes it impossible to check what was rated or when.

Figures were taken from each provider's own published terms on 3 October 2026. Variable rates can change at any time — confirm the current rate with the provider before applying.